BETH KNOX: Open Payments
NPI 1831424266 · FORSYTH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 31 payments from 13 companies in 2025. Trend: 2023 $676 · 2024 $793 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $186 |
| Globus Medical, Inc. | 2 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Novo Nordisk Inc | 3 | $52 |
| ABBVIE INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| Astellas Pharma US Inc | 1 | $31 |
| Abbott Laboratories | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: AIRSUPRA, Senza, FARXIGA, REXULTI, Ozempic, BREZTRI, Veozah, FREESTYLE LIBRE.
Industry payments across MO — which companies pay providers there.
